IgM paraprotein and anti-MAG sensory polyneuropathy associated with Waldenstrom’s macroglobulinaemia and medullary carcinoma of the thyroid
- 23 February 2021
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 14 (2), e240242
- https://doi.org/10.1136/bcr-2020-240242
Abstract
A previously fit and well 76-year-old man, presented with distal lower limb sensory symptoms suggestive of peripheral sensory neuropathy, associated with positive anti-MAG antibodies (myelin associated glycoprotein) and IgM paraprotein. Bone marrow biopsy showed lymphoplasmocytoid lymphoma (Waldenstrom’s macroglobulinaemia, WM), consequently positive for MYD88 mutation. He subsequently developed medullary carcinoma of the thyroid, most likely secondary to WM. He underwent a successful total thyroidectomy and four treatment doses of rituximab, which proved beneficial. He is currently stable and under multidisciplinary monitoring. His sensory symptoms have improved following rituximab treatment and his WM is under control.Keywords
This publication has 11 references indexed in Scilit:
- Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathiesCochrane Database of Systematic Reviews, 2016
- Heterogeneity of Polyneuropathy Associated with Anti-MAG AntibodiesClinical and Developmental Immunology, 2015
- Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER databaseCancer, 2015
- Prevalence, specificity and functionality of anti-ganglioside antibodies in neuropathy associated with IgM monoclonal gammopathyJournal of Neuroimmunology, 2014
- An Update on Monoclonal Gammopathy and NeuropathyCurrent Neurology and Neuroscience Reports, 2011
- Risk of second cancers in Waldenström macroglobulinemiaAnnals Of Oncology, 2011
- The Neuropathies of Waldenström's Macroglobulinemia (WM) and IgM-MGUSCanadian Journal of Neurological Sciences, 2011
- Placebo‐controlled trial of rituximab in IgM anti–myelin‐associated glycoprotein antibody demyelinating neuropathyAnnals of Neurology, 2009
- The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemiaZeitschrift für Neurologie, 1991
- Myelin‐Associated Glycoprotein Is the Antigen for a Monoclonal IgM in PolyneuropathyJournal of Neurochemistry, 1982